Evolution and Phenotypic Selection of Cancer Stem Cells

Cells of different organs at different ages have an intrinsic set of kinetics that dictates their behavior. Transformation into cancer cells will inherit these kinetics that determine initial cell and tumor population progression dynamics. Subject to genetic mutation and epigenetic alterations, cancer cell kinetics can change, and favorable alterations that increase cellular fitness will manifest themselves and accelerate tumor progression. We set out to investigate the emerging intratumoral heterogeneity and to determine the evolutionary trajectories of the combination of cell-intrinsic kinetics that yield aggressive tumor growth. We develop a cellular automaton model that tracks the temporal evolution of the malignant subpopulation of so-called cancer stem cells(CSC), as these cells are exclusively able to initiate and sustain tumors. We explore orthogonal cell traits, including cell migration to facilitate invasion, spontaneous cell death due to genetic drift after accumulation of irreversible deleterious mutations, symmetric cancer stem cell division that increases the cancer stem cell pool, and telomere length and erosion as a mitotic counter for inherited non-stem cancer cell proliferation potential. Our study suggests that cell proliferation potential is the strongest modulator of tumor growth. Early increase in proliferation potential yields larger populations of non-stem cancer cells(CC) that compete with CSC and thus inhibit CSC division while a reduction in proliferation potential loosens such inhibition and facilitates frequent CSC division. The sub-population of cancer stem cells in itself becomes highly heterogeneous dictating population level dynamics that vary from long-term dormancy to aggressive progression. Our study suggests that the clonal diversity that is captured in single tumor biopsy samples represents only a small proportion of the total number of phenotypes.

[1]  R. Weinberg,et al.  Cell plasticity and heterogeneity in cancer. , 2013, Clinical chemistry.

[2]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[3]  H. Enderling Cancer stem cells and tumor dormancy. , 2013, Advances in experimental medicine and biology.

[4]  Rolf Bjerkvig,et al.  Opinion: the origin of the cancer stem cell: current controversies and new insights. , 2005, Nature reviews. Cancer.

[5]  Alissa M. Weaver,et al.  Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment , 2006, Cell.

[6]  R. Levine,et al.  A progenitor cell origin of myeloid malignancies , 2009, Proceedings of the National Academy of Sciences.

[7]  S. McWeeney,et al.  Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. , 2010, Cancer research.

[8]  Rolf Bjerkvig,et al.  The origin of the cancer stem cell: current controversies and new insights , 2005, Nature Reviews Cancer.

[9]  E. Blackburn,et al.  A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. , 1978, Journal of molecular biology.

[10]  Larry Norton,et al.  Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. , 2005, The oncologist.

[11]  Jacob G Scott,et al.  Microenvironmental variables must influence intrinsic phenotypic parameters of cancer stem cells to affect tumourigenicity , 2014, PLoS Comput. Biol..

[12]  M. Chaplain,et al.  Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. , 2009, Cancer research.

[13]  M. A. Goldman The role of telomeres and telomerase in cancer. , 2003, Drug discovery today.

[14]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[15]  R. Yi,et al.  Stem cell quiescence acts as a tumor suppressor in squamous tumors , 2013, Nature Cell Biology.

[16]  M. Wicha,et al.  Symmetric Division of Cancer Stem Cells – a Key Mechanism in Tumor Growth that should be Targeted in Future Therapeutic Approaches , 2007, Clinical pharmacology and therapeutics.

[17]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.

[18]  J. Radich,et al.  An evolutionary explanation for the presence of cancer nonstem cells in neoplasms , 2012, Evolutionary applications.

[19]  Jeffrey Wyckoff,et al.  Cell migration in tumors. , 2005, Current opinion in cell biology.

[20]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[21]  Philip Hahnfeldt,et al.  Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype , 2010, Biology Direct.

[22]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[23]  Ingo Röder,et al.  Stem Cell Proliferation and Quiescence—Two Sides of the Same Coin , 2009, PLoS Comput. Biol..

[24]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[25]  José Manuel García-Aznar,et al.  A mathematical model for cell differentiation, as an evolutionary and regulated process , 2014, Computer methods in biomechanics and biomedical engineering.

[26]  Tom H. Cheung,et al.  Molecular regulation of stem cell quiescence , 2013, Nature Reviews Molecular Cell Biology.

[27]  C. Wilke,et al.  The traveling-wave approach to asexual evolution: Muller's ratchet and speed of adaptation. , 2007, Theoretical population biology.

[28]  H. Welch,et al.  Overdiagnosis in cancer. , 2010, Journal of the National Cancer Institute.

[29]  Jacques Bélair,et al.  Oscillations in cyclical neutropenia: new evidence based on mathematical modeling. , 2003, Journal of theoretical biology.

[30]  P. Hahnfeldt,et al.  Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features , 2013, Front. Oncol..

[31]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Furth,et al.  The Transmission of Leukemia of Mice with a Single Cell , 1937 .

[33]  H. Muller Some Genetic Aspects of Sex , 1932, The American Naturalist.

[34]  C. Potten,et al.  The small intestine as a model for evaluating adult tissue stem cell drug targets 1 , 2003, Cell proliferation.

[35]  D. Tang,et al.  Understanding cancer stem cell heterogeneity and plasticity , 2012, Cell Research.

[36]  W C Black,et al.  Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. , 1993, The New England journal of medicine.

[37]  C. Chou,et al.  Spatiotemporal dynamics of the biological interface between cancer and the microenvironment: a fractal anomalous diffusion model with microenvironment plasticity , 2012, Theoretical Biology and Medical Modelling.

[38]  Aleksandar Dakic,et al.  Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.

[39]  David Zurakowski,et al.  A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. , 2006, Journal of the National Cancer Institute.

[40]  P. Hahnfeldt,et al.  Biphasic modulation of cancer stem cell‐driven solid tumour dynamics in response to reactivated replicative senescence , 2014, Cell proliferation.

[41]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[42]  C. Blanpain,et al.  Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.

[43]  S. Frank Dynamics of Cancer: Incidence, Inheritance, and Evolution , 2007 .

[44]  A M Olovnikov,et al.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.

[45]  Lynn Hlatky,et al.  Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Jan Poleszczuk,et al.  A High-Performance Cellular Automaton Model of Tumor Growth with Dynamically Growing Domains. , 2013, Applied mathematics.

[47]  P Hahnfeldt,et al.  Migration rules: tumours are conglomerates of self-metastases , 2009, British Journal of Cancer.

[48]  John Cairns,et al.  Mutation selection and the natural history of cancer , 1975, Nature.

[49]  I. Weissman,et al.  Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. , 2003, Blood.

[50]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[51]  R. Raychowdhury,et al.  Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. , 2009, Cancer research.

[52]  E. Holland,et al.  The Probable Cell of Origin of NF1- and PDGF-Driven Glioblastomas , 2011, PloS one.

[53]  A. Anderson,et al.  A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. , 2005, Mathematical medicine and biology : a journal of the IMA.

[54]  Emmanuel Tannenbaum,et al.  Evolutionary dynamics of adult stem cells: comparison of random and immortal-strand segregation mechanisms. , 2004, Physical review. E, Statistical, nonlinear, and soft matter physics.

[55]  Steven A. Frank,et al.  Dynamics of Cancer , 2007 .

[56]  Trachette L. Jackson,et al.  Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny. , 2008, Neoplasia.

[57]  A. Brack,et al.  Muscle stem cells and reversible quiescence: The role of sprouty , 2010, Cell cycle.

[58]  E. Holland,et al.  The Therapeutic Implications of Plasticity of the Cancer Stem Cell Phenotype , 2010, PloS one.

[59]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[60]  Philip Hahnfeldt,et al.  The Tumor Growth Paradox and Immune System-Mediated Selection for Cancer Stem Cells , 2013, Bulletin of mathematical biology.

[61]  Philip Hahnfeldt,et al.  Non-stem cancer cell kinetics modulate solid tumor progression , 2011, Theoretical Biology and Medical Modelling.

[62]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[63]  J. Shay,et al.  Telomeres and telomerase in normal and cancer stem cells , 2010, FEBS letters.

[64]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.